Clinical trials, made visible
Tracking trials relevant to underrepresented communities — who they're for, when they open, and how to reach them.
Open trials
OpenNCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Open to all qualified participants
OpenNCT07491497
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Open to all qualified participants
OpenNCT05669846
Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
Open to all qualified participants
Partner institutions
HB
HBCUDI
Divine Nine OrganizationBL
Black Medical Association